Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
21.93B | 19.79B | 19.74B | 19.70B | 18.77B | 20.32B | Gross Profit |
4.18B | 3.49B | 3.63B | 3.96B | 3.48B | 3.90B | EBIT |
1.22B | 388.00M | 452.00M | 988.00M | 554.00M | 776.00M | EBITDA |
1.85B | -189.00M | 959.00M | 1.42B | 1.01B | 1.25B | Net Income Common Stockholders |
-235.00M | -873.00M | 524.00M | 1.06B | 968.00M | 591.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.89B | 3.90B | 4.43B | 5.55B | 4.62B | 3.51B | Total Assets |
33.10B | 30.29B | 27.62B | 27.67B | 26.46B | 24.11B | Total Debt |
6.79B | 6.24B | 3.52B | 3.27B | 4.15B | 2.03B | Net Debt |
3.90B | 2.42B | 188.00M | -1.15B | 692.00M | -1.48B | Total Liabilities |
14.47B | 12.96B | 10.27B | 10.78B | 10.35B | 9.12B | Stockholders Equity |
18.62B | 17.33B | 17.35B | 16.89B | 16.11B | 14.99B |
Cash Flow | Free Cash Flow | ||||
0.00 | -2.23B | -1.14B | 2.38B | -2.02B | 204.00M | Operating Cash Flow |
0.00 | -1.07B | -506.00M | 3.05B | -1.27B | 1.19B | Investing Cash Flow |
0.00 | -871.00M | -608.00M | -544.00M | -635.00M | -1.05B | Financing Cash Flow |
0.00 | 2.48B | 22.00M | -1.61B | 1.88B | 35.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥12.21B | 9.59 | 2.23% | 2.63% | 267.72% | ||
80 Outperform | ¥13.64B | 10.80 | 3.43% | -6.96% | -1.73% | ||
79 Outperform | ¥13.18B | 9.41 | 2.71% | 20.91% | 18.64% | ||
78 Outperform | ¥13.50B | 11.98 | 2.47% | 16.80% | 29.50% | ||
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% | |
64 Neutral | ¥13.43B | 17.42 | 1.85% | 25.48% | ― | ||
58 Neutral | ¥12.53B | ― | 5.73% | -6.30% | 34.61% |